Regenerons

Regeneron’s antibody cocktail cuts the risk of hospitalization or death due to COVID-19 by 70%

by

Regeneron’s coronavirus antibody cocktail is effective at treating mild to moderate cases of COVID-19, new late-stage trial results suggest. The treatment is a mixture of drugs casirivimab and imdevimab, and was developed by the New York City-based company in partnership with pharmaceutical firm Roche.  Known as REGEN-COV, the cocktail imitates antibodies that the body generates … Read more

Oxford University to test Regeneron’s ‘antibody cocktail’ on hospitalised Covid-19 patients

by

Doctors in the UK will trial an experimental ‘antibody cocktail’ medicine on patients in hospital with Covid-19. The Oxford University team behind the pioneering RECOVERY trial in Britain, which discovered that the steroid dexamethasone can save patients’ lives, have announced the newest addition to their study. It is a therapy called REGN-COV2 made by the … Read more